175 related articles for article (PubMed ID: 36864331)
21. A retrospective, matched cohort study of potential drug-drug interaction prevalence and opioid utilization in a diabetic peripheral neuropathy population initiated on pregabalin or duloxetine.
Ellis JJ; Sadosky AB; Ten Eyck LL; Mudumby P; Cappelleri JC; Ndehi L; Suehs BT; Parsons B
BMC Health Serv Res; 2015 Apr; 15():159. PubMed ID: 25889173
[TBL] [Abstract][Full Text] [Related]
22. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
[TBL] [Abstract][Full Text] [Related]
23. Propensity score estimation to address calendar time-specific channeling in comparative effectiveness research of second generation antipsychotics.
Dusetzina SB; Mack CD; Stürmer T
PLoS One; 2013; 8(5):e63973. PubMed ID: 23667693
[TBL] [Abstract][Full Text] [Related]
24. Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis.
Rudroju N; Bansal D; Talakokkula ST; Gudala K; Hota D; Bhansali A; Ghai B
Pain Physician; 2013; 16(6):E705-14. PubMed ID: 24284851
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics, pharmacotherapy, and healthcare resource use among patients with diabetic neuropathy newly prescribed pregabalin or gabapentin.
Gore M; Tai KS; Zlateva G; Bala Chandran A; Leslie D
Pain Pract; 2011; 11(6):528-39. PubMed ID: 21435162
[TBL] [Abstract][Full Text] [Related]
26. Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
van Nooten F; Treur M; Pantiri K; Stoker M; Charokopou M
Clin Ther; 2017 Apr; 39(4):787-803.e18. PubMed ID: 28365034
[TBL] [Abstract][Full Text] [Related]
27. Effect of levetiracetam versus gabapentin on peripheral neuropathy and sciatic degeneration in streptozotocin-diabetic mice: Influence on spinal microglia and astrocytes.
Reda HM; Zaitone SA; Moustafa YM
Eur J Pharmacol; 2016 Jan; 771():162-72. PubMed ID: 26712375
[TBL] [Abstract][Full Text] [Related]
28. Assessing the Value of Time Series Real-World and Clinical Trial Data vs. Baseline-Only Data in Predicting Responses to Pregabalin Therapy for Patients with Painful Diabetic Peripheral Neuropathy.
Alexander J; Edwards RA; Brodsky M; Savoldelli A; Manca L; Grugni R; Emir B; Whalen E; Watt S; Parsons B
Clin Drug Investig; 2019 Aug; 39(8):775-786. PubMed ID: 31243706
[TBL] [Abstract][Full Text] [Related]
29. Evidence-Based Review of Pharmacotherapy Used for Parkinson's Disease Psychosis.
Wilby KJ; Johnson EG; Johnson HE; Ensom MHH
Ann Pharmacother; 2017 Aug; 51(8):682-695. PubMed ID: 28385039
[TBL] [Abstract][Full Text] [Related]
30. Integrating data from randomized controlled trials and observational studies to predict the response to pregabalin in patients with painful diabetic peripheral neuropathy.
Alexander J; Edwards RA; Savoldelli A; Manca L; Grugni R; Emir B; Whalen E; Watt S; Brodsky M; Parsons B
BMC Med Res Methodol; 2017 Jul; 17(1):113. PubMed ID: 28728577
[TBL] [Abstract][Full Text] [Related]
31. A Brief Review on the Novel Therapies for Painful Diabetic Neuropathy.
Basem JI; Bah FN; Mehta ND
Curr Pain Headache Rep; 2023 Sep; 27(9):299-305. PubMed ID: 37392335
[TBL] [Abstract][Full Text] [Related]
32. Impact of a Novel Cost-Saving Pharmacy Program on Pregabalin Use and Health Care Costs.
Martin C; Odell K; Cappelleri JC; Bancroft T; Halpern R; Sadosky A
J Manag Care Spec Pharm; 2016 Feb; 22(2):132-44. PubMed ID: 27015252
[TBL] [Abstract][Full Text] [Related]
33. Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
Terman SW; Youngerman BE; Choi H; Burke JF
Epilepsia; 2022 Jun; 63(6):1571-1579. PubMed ID: 35294775
[TBL] [Abstract][Full Text] [Related]
34. Anticonvulsants for fibromyalgia.
Üçeyler N; Sommer C; Walitt B; Häuser W
Cochrane Database Syst Rev; 2013 Oct; (10):CD010782. PubMed ID: 24129853
[TBL] [Abstract][Full Text] [Related]
35. Costs of pregabalin or gabapentin for painful diabetic peripheral neuropathy.
Udall M; Harnett J; Mardekian J
J Med Econ; 2012; 15(2):361-70. PubMed ID: 22181052
[TBL] [Abstract][Full Text] [Related]
36. Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis.
Brown JD; Cicali B; Henriksen C; Malaty I; Okun MS; Armstrong MJ
J Manag Care Spec Pharm; 2021 Jun; 27(6):785-790. PubMed ID: 34057395
[No Abstract] [Full Text] [Related]
37. Patients treated with pimavanserin or quetiapine for Parkinson's disease psychosis: analysis of health resource utilization patterns among Medicare beneficiaries.
Rajagopalan K; Rashid N; Doshi D
J Med Econ; 2023; 26(1):769-776. PubMed ID: 37272069
[TBL] [Abstract][Full Text] [Related]
38. Long-term cost-effectiveness of initiating treatment for painful diabetic neuropathy with pregabalin, duloxetine, gabapentin, or desipramine.
Bellows BK; Nelson RE; Oderda GM; LaFleur J
Pain; 2016 Jan; 157(1):203-213. PubMed ID: 26397932
[TBL] [Abstract][Full Text] [Related]
39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
40. Comparative role of pregabalin and carbamazepine regarding efficacy in painful diabetic neuropathy.
Mahmood R; Jawed I; Khan MI; Mahmood I; Tariq T; Kamil A; Sayeed FZ; Sayeed BZ
Pak J Pharm Sci; 2017 Jul; 30(4):1275-1278. PubMed ID: 29039325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
